BEGIN:VCALENDAR
PRODID:-//github.com/rianjs/ical.net//NONSGML ical.net 4.0//EN
VERSION:2.0
BEGIN:VEVENT
DESCRIPTION:The development of mono- and bivalent degraders continues to g
 ain traction\, but biopharma faces challenges in rapidly discovering\, va
 lidating\, and utilizing novel E3 ligases. This leaves therapeutic opport
 unities untapped due to obstacles in ligase screening\, structural charac
 terization\, and assaying therapeutic efficacy.\n\nThe Annual Ligase Targ
 eting Drug Development Summit\, now in its 4th year\, will unite 80+ liga
 se experts dedicated to tackling ligase bottlenecks through data-driven p
 resentations\, technical discussions\, and interactive sessions\, unlocki
 ng the potential of E3 ligases for novel drug targets.\n
DTEND:20240509T170000
DTSTAMP:20260514T153515Z
DTSTART:20240507T090000
LOCATION:The Colonnade Hotel\, 120\, Huntington Avenue\, Boston\, Massachu
 setts\, 02116\,
SEQUENCE:0
SUMMARY:The development of mono- and bivalent degraders continues to gain 
 traction\, but biopharma faces challenges in rapidly discovering\, valida
 ting\, and...
UID:8ea6927e-d226-49cf-9500-1b39796c0d58
END:VEVENT
END:VCALENDAR